Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis

Recruiting now · Not applicable

Conditions studied: Obstructive Jaundice, Biliary Stricture, Sphincter of Oddi Dysfunction

In brief

The use of an endoprothesis in a pancreatic duct is a measure to minimize the incidence and severity of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis. In this study we will evaluate the use of a Biodegradable Endoprothesis: Archimede Fast Biodegradable Pancreatic Stent in patients with high risk of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis.The ARCHIMEDES Fast biodegradable pancreatic stent will be placed during the Endoscopic Retrograde CholoangioPancreatography. The efficacy and the security of the device will be evaluated.

Key facts

Study ID

NCT03977779

Run by

Institut Paoli-Calmettes

People needed

46

Starts

2022-01-20

Expected to finish

2024-12-15

Last updated by the study team

2024-10-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age>18 years
• Patients at risk of developing a Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis (procedure and/or patient-related risk factors

You may not qualify if…

• Pregnant or breastfeeding women
• Recent diagnosis (<1 month) of acute pancreatitis
• contraindication to endoscopy
• Hypersensitivity to indomethacine

Where it is running

• Institut Paoli Calmettes — Marseille, Provence-Alpes-Côte d'Azur Region, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.